hnRNPA2B1 interacts with and stabilizes NEAT1 to activate the Wnt/β-catenin pathway, maintain stemness and aggravate chemotherapy resistance in GC (Wang J. et al., 2024). The gene discussed is HNRNPA2B1; the disease is gastric cancer.